Company: BACC
Filing Date: 2025-05-14
Form Type: S-1
Source: 0001185185-25-000465
Chunk: 17

Company: Blue Acquisition Corp/Cayman
Filing Date: 2025-05-14
Form: S-1
Chunk 17
---
Dr. Kenneth Moritsugu has been the President and Chief Executive Officer of First Samurai
Consulting, LLC, a firm specializing in health consulting focused on public health systems and policies since 2007. Rear Admiral Moritsugu
was the Acting Surgeon General of the United States in 2002 and again from July 2006 until his retirement from the Commissioned Corps
of the United States Public Health Service (USPHS) in September 2007. He served in several key HHS and government positions including
the Director of the Division of Medicine, Deputy Director of the Bureau of Health Professions, Director of the National Health Service
Corps, and Assistant Bureau Director for Health Services and Medical Director of the Federal Bureau of Prisons. He also was Vice President
for Global Professional Education and Strategic Relations for Johnson & Johnson’s Diabetes Solutions Companies, and former WorldWide
Chairman of the Johnson & Johnson Diabetes Institutes (JJDI), until his retirement from Johnson & Johnson in 2013.

Nadim Qureshi is the co-founder and
managing partner of BPGC Management LP, a private equity firm focused on transactions with the global industrials, materials and chemicals
sectors, where he is responsible for all aspects of firm and investment management. From 2018 to 2020, Mr. Qureshi served as Managing
Partner at Invesco Private Markets, a private investing division of Invesco Ltd., an investment management company, and from 2015 served
as Managing Director, and as Managing Partner of WL Ross & Co. LLC, a private equity firmfocused on investments in financially distressed companies with undervalued stocks, which since 2006 has been operating as a wholly owned subsidiary ofInvesco Ltd. From 2012 to 2015, Mr. Qureshi was a Partner at Quinpario
Partners LLC, a private equity firm. From 2005 to 2012, he was a senior executive with Solutia, Inc. (as Senior Vice President, Emerging
Markets from August 2011), and part of the management team that led the restructuring and transformation of Solutia from a bankrupt commodity
producer to a profitable specialty chemicals business until its sale to Eastman Chemical in 2012. From 2000 to 2005, Mr. Qureshi worked
at Arthur D. Little, a global management consulting firm, and Charles River Associates, a global consulting firm. Mr. Qureshi